Advanced signet-ring cell carcinoma of the stomach: Clinicopathological characteristics of patients and efficacy of the modified docetaxel, cisplatin, and fluorouracil regimen


Bozkaya Y., Erdem G. U. , Ozdemir N. Y. , Hocazade C., Yazici O., Demirci N. S. , ...More

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, vol.14, 2018 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 14
  • Publication Date: 2018
  • Doi Number: 10.4103/0973-1482.184514
  • Journal Name: JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED)
  • Keywords: Gastric cancer, modified docetaxel, cisplatin, and fluorouracil, prognosis, signet-ring cell carcinoma, ADVANCED GASTRIC-CANCER, 1ST-LINE TREATMENT, PROGNOSTIC VALUE, PHASE-III, ADENOCARCINOMA, HISTOLOGY, THERAPY, CLASSIFICATION, 5-FLUOROURACIL, CHEMOTHERAPY
  • Gazi University Affiliated: Yes

Abstract

Background: The aim of this retrospective study was to investigate the clinicopathological characteristics of patients with signet-ring cell carcinoma (SRCC) of the stomach, and the efficacy of the modified docetaxel, cisplatin, and fluorouracil (mDCF) chemotherapy regimen.